Cargando…
PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting
This editorial describes the results of discussions between the U.S. FDA Oncology Center of Excellence and members of six pharmaceutical companies—a forum aptly named PD‐1 Pandemonium—regarding development and regulatory approvals of immune checkpoint inhibitors.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516112/ https://www.ncbi.nlm.nih.gov/pubmed/31088980 http://dx.doi.org/10.1634/theoncologist.2019-0281 |
| _version_ | 1783418196077838336 |
|---|---|
| author | Bates, Susan E. |
| author_facet | Bates, Susan E. |
| author_sort | Bates, Susan E. |
| collection | PubMed |
| description | This editorial describes the results of discussions between the U.S. FDA Oncology Center of Excellence and members of six pharmaceutical companies—a forum aptly named PD‐1 Pandemonium—regarding development and regulatory approvals of immune checkpoint inhibitors. |
| format | Online Article Text |
| id | pubmed-6516112 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65161122019-06-20 PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting Bates, Susan E. Oncologist Editorial This editorial describes the results of discussions between the U.S. FDA Oncology Center of Excellence and members of six pharmaceutical companies—a forum aptly named PD‐1 Pandemonium—regarding development and regulatory approvals of immune checkpoint inhibitors. John Wiley & Sons, Inc. 2019-05-14 2019-05 /pmc/articles/PMC6516112/ /pubmed/31088980 http://dx.doi.org/10.1634/theoncologist.2019-0281 Text en © AlphaMed Press 2019 |
| spellingShingle | Editorial Bates, Susan E. PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title | PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title_full | PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title_fullStr | PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title_full_unstemmed | PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title_short | PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting |
| title_sort | pd‐1 pandemonium at the american association for cancer research annual meeting |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516112/ https://www.ncbi.nlm.nih.gov/pubmed/31088980 http://dx.doi.org/10.1634/theoncologist.2019-0281 |
| work_keys_str_mv | AT batessusane pd1pandemoniumattheamericanassociationforcancerresearchannualmeeting |